NEW YORK, Dec 13 – Ebioinformatics announced Wednesday that it has acquired life sciences data integration company Empatheon and changed its name to Entigen.

Entigen will continue to focus on bioinformatics but also plans to expand into new markets, which may include other scientific computing areas, said James Nelson, vice president of product marketing at Entigen. “We’re looking at many horizons,” he said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.